Insider · CIK 0001211701

BEHRENS M KATHLEEN

Reports to the SEC for 5 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001211701

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+16.9K sh	—	—	214,357
2026-01-27	SRPTSarepta Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−6,494 sh	$22.17	−$144K	197,482
2026-01-27	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+10.5K sh	—	—	0
2026-01-27	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10.5K sh	$13.71	+$144K	203,976
2025-08-14	IGM Biosciences, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−331K sh	—	—	0
2025-08-14	IGM Biosciences, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−29.8K sh	—	—	0
2025-08-14	IGM Biosciences, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−22.2K sh	—	—	0
2025-08-14	IGM Biosciences, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−29.8K sh	—	—	0
2025-06-30	IGM Biosciences, Inc.A Award	Director	AAward	+1,471 sh	—	—	22,222
2025-06-18	MDXGMIMEDX GROUP, INC.A Award	Director	AAward	+28.6K sh	$6.47	+$185K	212,771
2025-03-31	IGM Biosciences, Inc.A Award	Director	AAward	+1,471 sh	—	—	20,751
2025-03-10	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+2,383 sh	—	—	193,476
2025-03-10	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,792 sh	—	—	4,792
2024-12-31	IGM Biosciences, Inc.A Award	Director	AAward	+3,078 sh	—	—	19,280
2024-09-30	IGM Biosciences, Inc.A Award	Director	AAward	+3,078 sh	—	—	16,202
2024-09-04	SRPTSarepta Therapeutics, Inc.G Gift	Director	GGift	−746 sh	—	—	191,093
2024-07-03	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$13.90	+$209K	191,839
2024-07-03	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2024-06-28	IGM Biosciences, Inc.A Award	Director	AAward	+3,078 sh	—	—	13,124
2024-06-05	MDXGMIMEDX GROUP, INC.A Award	Director	AAward	+23.2K sh	$7.26	+$168K	184,162
2024-03-29	IGM Biosciences, Inc.A Award	Director	AAward	+3,078 sh	—	—	10,046
2024-03-12	IGM Biosciences, Inc.Stock Option (right to buy)A Award	Director	AAward	+29.4K sh	—	—	29,400
2024-03-01	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+1,846 sh	—	—	176,839
2024-03-01	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,679 sh	—	—	3,679
2023-12-29	IGM Biosciences, Inc.A Award	Director	AAward	+800 sh	—	—	6,968
2023-11-03	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$29.03	+$435K	174,993
2023-11-03	SRPTSarepta Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2023-09-29	IGM Biosciences, Inc.A Award	Director	AAward	+800 sh	—	—	6,168
2023-06-30	IGM Biosciences, Inc.A Award	Director	AAward	+800 sh	—	—	5,368
2023-06-26	IGM Biosciences, Inc.P Purchase	Director	PPurchase	+113K sh	$8.00	+$900K	330,700
2023-06-13	MDXGMIMEDX GROUP, INC.A Award	Director	AAward	+35.4K sh	$4.95	+$175K	160,972
2023-04-04	IGM Biosciences, Inc.Stock Option (right to buy)A Award	Director	AAward	+15.5K sh	—	—	15,500
2023-03-31	IGM Biosciences, Inc.A Award	Director	AAward	+800 sh	—	—	4,568
2023-03-06	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+1,523 sh	—	—	159,993
2023-03-06	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,257 sh	—	—	3,257
2022-12-30	IGM Biosciences, Inc.A Award	Director	AAward	+374 sh	—	—	3,768
2022-12-19	SRPTSarepta Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2022-12-19	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$34.92	+$698K	158,470
2022-11-08	IGM Biosciences, Inc.P Purchase	Director	PPurchase	+60K sh	$17.14	+$1.03M	218,200
2022-09-30	IGM Biosciences, Inc.A Award	Director	AAward	+374 sh	—	—	3,394
2022-06-30	IGM Biosciences, Inc.A Award	Director	AAward	+374 sh	—	—	3,020
2022-06-07	MDXGMIMEDX GROUP, INC.A Award	Director	AAward	+44.2K sh	$3.96	+$175K	125,618
2022-04-01	IGM Biosciences, Inc.P Purchase	Director	PPurchase	+8,695 sh	$23.00	+$200K	29,806
2022-04-01	IGM Biosciences, Inc.P Purchase	Director	PPurchase	+8,696 sh	$23.00	+$200K	29,807
2022-04-01	IGM Biosciences, Inc.P Purchase	Director	PPurchase	+43.5K sh	$23.00	+$1M	158,200
2022-03-31	IGM Biosciences, Inc.A Award	Director	AAward	+374 sh	—	—	2,646
2022-03-12	IGM Biosciences, Inc.Stock Option (right to buy)A Award	Director	AAward	+29.5K sh	—	—	29,497
2022-03-07	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,077 sh	—	—	5,077
2022-03-07	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+2,953 sh	—	—	138,470
2021-12-31	IGM Biosciences, Inc.A Award	Director	AAward	+211 sh	—	—	2,272

Recent filings

Accepted (ET)
Jun 54
BEHRENS M KATHLEEN0001193125-26-260257
SEC(opens sec.gov)
Jan 294
BEHRENS M KATHLEEN0001193125-26-029893
SEC(opens sec.gov)
Aug 144
BEHRENS M KATHLEEN0001415889-25-021950
SEC(opens sec.gov)
Jul 24
BEHRENS M KATHLEEN0001415889-25-019152
SEC(opens sec.gov)
Jun 234
BEHRENS M KATHLEEN0001376339-25-000072
SEC(opens sec.gov)
Apr 24
BEHRENS M KATHLEEN0001415889-25-009777
SEC(opens sec.gov)
Mar 114
BEHRENS M KATHLEEN0000950170-25-037511
SEC(opens sec.gov)
Jan 34
BEHRENS M KATHLEEN0001415889-25-000608
SEC(opens sec.gov)
Oct 24
BEHRENS M KATHLEEN0001415889-24-024533
SEC(opens sec.gov)
Sep 54
BEHRENS M KATHLEEN0000950170-24-104194
SEC(opens sec.gov)
Jul 84
BEHRENS M KATHLEEN0000950170-24-082240
SEC(opens sec.gov)
Jul 24
BEHRENS M KATHLEEN0001415889-24-019056
SEC(opens sec.gov)
Jun 64
BEHRENS M KATHLEEN0001376339-24-000047
SEC(opens sec.gov)

Companies

Address

215 FIRST STREET SUITE 415

CAMBRIDGE, MA, 02142